The New Option in Low-Dose Oral Contraception: Expanding the Gestodene Choice
Author:   S.R. Killick ,  P. Lopes
Publisher:   Taylor & Francis Ltd
ISBN:  

9781850707394


Pages:   70
Publication Date:   15 March 1996
Format:   Hardback
Availability:   Out of stock   Availability explained


Our Price $263.87 Quantity:  
Add to Cart

Share |

The New Option in Low-Dose Oral Contraception: Expanding the Gestodene Choice


Overview

This is a high-level medical text on the advantages and disadvantages of the newest low-dose oral contraceptives. The contributors are leading investigators in the development of new contraceptives whose four main chapters describe the latest clinical results and scientific studies analyzing the efficacy, cycle control, and tolerability of low-dose pills combining ethinylestradiol and gestodene or ethinylestradiol and desogestrel. The book also contains a chapter on the influence of low-dose oral contraceptives on lipid and carbohydrate metabolism and hemostasis.

Full Product Details

Author:   S.R. Killick ,  P. Lopes
Publisher:   Taylor & Francis Ltd
Imprint:   Informa Healthcare
Dimensions:   Width: 18.90cm , Height: 1.10cm , Length: 23.00cm
Weight:   0.381kg
ISBN:  

9781850707394


ISBN 10:   1850707391
Pages:   70
Publication Date:   15 March 1996
Audience:   College/higher education ,  Professional and scholarly ,  Postgraduate, Research & Scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Out of Print
Availability:   Out of stock   Availability explained

Table of Contents

Reasons for developing a 20 g ethinylestradiol pill containing gestodene o Three years' clinical experience with a new low-dose oral contraceptive containing 20 g ethinylestradiol and 75 g gestodene: efficacy, cycle control, and tolerability o A 12-month comparative investigation of reliability, cycle control, and tolerance with low-dose oral contraceptives containing 20 g ethinylestradiol and either 75 g gestodene or 150 g desogestrel o The influence of a low-dose contraceptive containing 20 g ethinylestradiol and 75 g gestodene on lipid and carbohydrate metabolism and hemostasis o Conclusions o Index.

Reviews

Author Information

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

NOV RG 20252

 

Shopping Cart
Your cart is empty
 Shopping cart
Mailing List

 

Sign up now